Gemma Gatta

Author PubWeight™ 62.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007 8.05
2 Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008 7.18
3 Gastric cancer. Crit Rev Oncol Hematol 2009 2.87
4 Incidence of uveal melanoma in Europe. Ophthalmology 2007 2.30
5 Major and minor salivary gland tumors. Crit Rev Oncol Hematol 2009 1.77
6 Ovarian cancer. Crit Rev Oncol Hematol 2006 1.64
7 Colon cancer. Crit Rev Oncol Hematol 2010 1.62
8 Cholangiocarcinoma. Crit Rev Oncol Hematol 2008 1.59
9 Glioblastoma in adults. Crit Rev Oncol Hematol 2008 1.54
10 Ependymoma. Crit Rev Oncol Hematol 2007 1.41
11 Cancer of the penis. Crit Rev Oncol Hematol 2005 1.39
12 Germ cell tumours of the testis. Crit Rev Oncol Hematol 2005 1.37
13 Adult acute myeloid leukaemia. Crit Rev Oncol Hematol 2004 1.37
14 Long-term survival expectations of cancer patients in Europe in 2000-2002. Eur J Cancer 2008 1.35
15 Cancer of the prostate. Crit Rev Oncol Hematol 2005 1.31
16 The cure of cancer: a European perspective. Eur J Cancer 2009 1.31
17 Cancer of the larynx. Crit Rev Oncol Hematol 2003 1.19
18 Incidence of and survival from Wilms' tumour in adults in Europe: data from the EUROCARE study. Eur J Cancer 2006 1.18
19 Adult acute lymphoblastic leukaemia. Crit Rev Oncol Hematol 2004 1.17
20 Anaplastic astrocytoma in adults. Crit Rev Oncol Hematol 2007 1.17
21 Gastric cancer. Crit Rev Oncol Hematol 2005 1.16
22 The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project. Tumori 2012 1.15
23 Survival in patients with uveal melanoma in Europe. Arch Ophthalmol 2008 1.11
24 Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study. BMJ Open 2013 1.10
25 Survival from salivary glands adenoid cystic carcinoma in European populations. Oral Oncol 2008 1.08
26 Oligodendroglioma. Crit Rev Oncol Hematol 2008 1.01
27 Explaining gastric cancer survival differences among European countries. Int J Cancer 2004 1.00
28 Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET). Crit Rev Oncol Hematol 2009 0.99
29 Cancer of the nasopharynx. Crit Rev Oncol Hematol 2003 0.97
30 Renal cancer. Crit Rev Oncol Hematol 2007 0.96
31 Childhood medulloblastoma. Crit Rev Oncol Hematol 2010 0.92
32 Human papillomavirus in HNSCC: a European epidemiologic perspective. Hematol Oncol Clin North Am 2008 0.92
33 Colon cancer. Crit Rev Oncol Hematol 2004 0.89
34 Comparing cancer care, outcomes, and costs across health systems: charting the course. J Natl Cancer Inst Monogr 2013 0.86
35 Rectal cancer. Crit Rev Oncol Hematol 2008 0.84
36 International collaborations in cancer control and the Third International Cancer Control Congress. Tumori 2009 0.81
37 Estimates of cancer burden in Italy. Tumori 2013 0.80
38 Cancer burden estimates and forecasts: uses and cautions. Tumori 2013 0.80
39 Rectal cancer. Crit Rev Oncol Hematol 2004 0.80
40 Bladder cancer. Crit Rev Oncol Hematol 2002 0.80
41 Management of adults with Wilms' tumor: recommendations based on international consensus. Expert Rev Anticancer Ther 2011 0.79
42 Regional estimates of prostate cancer burden in Italy. Tumori 2007 0.77
43 Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project. Cancer Epidemiol 2013 0.76
44 Cancer of pancreas. Crit Rev Oncol Hematol 2004 0.76
45 Estimates of cancer burden in Veneto. Tumori 2013 0.75
46 [Case-control evaluation of screening efficacy]. Epidemiol Prev 2005 0.75
47 Estimates of cancer burden in Puglia. Tumori 2013 0.75
48 Estimates of cancer burden in Lombardy. Tumori 2013 0.75